NCT07751393

Brief Summary

This study will look at certain proteins in the gums, saliva, and gum fluid of people with healthy gums, gingivitis (mild gum inflammation), or periodontitis (more severe gum disease). The proteins to be studied called STAP-1, STAP-2, STAT3, STAT5A, NLRP3, and CASP3, are known to be involved in inflammation and cell health in other diseases, but their role in gum disease is not well understood. Seventy-five healthy adults will be grouped by their gum health status. Samples of saliva and gum fluid will be collected and tested, and gum tissue samples will be collected from a subset of participants during routine dental treatment. Researchers will measure the levels of these proteins and look for patterns linking them to the severity of gum disease. The results are expected to show whether these proteins are found at different levels in people with periodontitis compared to those with healthy gums, suggesting they may play a role in how gum disease develops and progresses. This information may help researchers better understand the biological processes behind periodontal disease and could eventually contribute to new ways of detecting or treating it.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

August 3, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 7, 2026

Completed
Last Updated

August 7, 2026

Status Verified

August 1, 2026

Enrollment Period

7 months

First QC Date

August 3, 2026

Last Update Submit

August 3, 2026

Conditions

Keywords

periodontitisgingivitisSTAP familyinflammationGCF

Outcome Measures

Primary Outcomes (1)

  • GCF, saliva and Gingival levels of STAP-1, STAP-2, STAT3, STAT5A, NLRP3 and CASP3

    Gene expression (RT-PCR, relative fold change via 2\^-ΔΔCT method)levels of STAP-1, STAP-2, STAT3, STAT5A, NLRP3 and CASP3 were measured in gingiva of participants. Protein levels of STAP-1, STAP-2, STAT3, STAT5A, NLRP3 and CASP3 in GCF and saliva were measured by ELISA in study participants.

    From may to December 2024

Study Arms (3)

periodontally healthy

periodontally healthy participants

gingivitis

patients with gingivitis

periodontitis

patients with periodontitis

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults aged 18 to 60 years attending the periodontology clinic were enrolled and classified into three groups based on clinical periodontal parameters according to the 2017 World Workshop classification: periodontal health, gingivitis, and periodontitis (Stage III). Exclusion criteria included any systemic disease, regular medication use, smoking, pregnancy or lactation, periodontal treatment within the past 6 months, antibiotic use within the past 6 months, and presence of prosthetic restorations on the teeth to be sampled. A total of 75 participants (25 per group; 38 male, 37 female) were included.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kubra Aral , Phd Ext. 422 341 01 06 kubra.aral@inonu.edu.tr

Malatya, 44100, Turkey (Türkiye)

Location

Related Publications (4)

  • Aral K, Aral CA, Kapila Y. The role of caspase-8, caspase-9, and apoptosis inducing factor in periodontal disease. J Periodontol. 2019 Mar;90(3):288-294. doi: 10.1002/JPER.17-0716. Epub 2018 Oct 26.

    PMID: 30311940BACKGROUND
  • Aral K, Milward MR, Kapila Y, Berdeli A, Cooper PR. Inflammasomes and their regulation in periodontal disease: A review. J Periodontal Res. 2020 Aug;55(4):473-487. doi: 10.1111/jre.12733. Epub 2020 Jan 20.

    PMID: 31960443BACKGROUND
  • Luo L, Wang F, Xu X, Ma M, Kuang G, Zhang Y, Wang D, Li W, Zhang N, Zhao K. STAT3 promotes NLRP3 inflammasome activation by mediating NLRP3 mitochondrial translocation. Exp Mol Med. 2024 Sep;56(9):1980-1990. doi: 10.1038/s12276-024-01298-9. Epub 2024 Sep 2.

    PMID: 39218978BACKGROUND
  • Kashiwakura JI, Oritani K, Matsuda T. The Functional Properties and Physiological Roles of Signal-Transducing Adaptor Protein-2 in the Pathogenesis of Inflammatory and Immune Disorders. Biomedicines. 2022 Nov 30;10(12):3079. doi: 10.3390/biomedicines10123079.

    PMID: 36551835BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Residual gingival crevicular fluid (GCF) samples will be retained as backup specimens in case repeat ELISA analysis is required due to technical issues (e.g., assay failure, insufficient sample volume, or inconclusive results). Retained samples will not be used for DNA extraction and will be stored at -80°C.

MeSH Terms

Conditions

PeriodontitisGingivitisInflammation

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesInfectionsGingival DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 3, 2026

First Posted

August 7, 2026

Study Start

May 1, 2024

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

August 7, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

De-identified individual participant data will be shared, including participant age, sex, and clinical periodontal parameters (plaque index, gingival index, probing depth, clinical attachment level, bleeding on probing). Participants will be identified only by coded/numbered case report forms; no names, gender identity beyond biological sex, or other identifying information will be shared.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 6 months and ending 24 months following article publication
Access Criteria
Data will be made available to researchers who provide a methodologically sound proposal, subject to approval by the corresponding author, for the purpose of achieving the aims outlined in the approved proposal.

Locations